HOME > TOP STORIES

TOP STORIES

BUSINESS Boehringer Said to Consider Nixing Allowances for Some Wholesalers, Denies Intention to Narrow Distributors

July 23, 2019
REGULATORY MHLW Panel to Review Tecentriq’s SCLC Use and More for September OK

July 23, 2019
BUSINESS Nitto Pharma Accelerating Development of Gut Bacteria Drugs, Eyes Clinical Studies within 3 Years

July 22, 2019
ORGANIZATION Experts Talk over Biosimilar Challenges, Chide Unstable Supplies and Indication Gaps

July 19, 2019
BUSINESS IPO Pending, StemRIM Looks to File World’s 1st Regeneration-Inducing Med Next Year: CEO

July 18, 2019
BUSINESS Astellas Hitches Frequency’s Regenerative Hearing Loss Therapy Outside US

July 18, 2019
ORGANIZATION Towards 2020 Reform, JPMA Wants Its Three-Pronged Proposal to Resonate with Public

July 17, 2019
BUSINESS Takeda Gears Up for Clinical Testing of 1st iPS-Derived CAR-T, Eyes Trial Launch in 2021

July 17, 2019
TRENDS Japan SGLT2 Market Hits 70 Billion Yen as Combo Drugs Gain Ground

July 16, 2019
BUSINESS Simone Thomsen Tapped as Lilly Japan Chief; Patrik Jonsson to Take Big Job at HQ

July 12, 2019
ACADEMIA Drugs to Replace Nucleic Acid Analogs Being Developed for Hepatitis B, with Focus on Elimination of HBs Antigens

July 12, 2019
ACADEMIA NCC Pitches Creation of New Panel to Address Info Gaps for Cancer Drugs, but Regional Hospitals Wary

July 11, 2019
BUSINESS Life Science Institute Begins Muse Cell Trial for Spinal Injury; President Confident of Profitability

July 10, 2019
BUSINESS Daiichi Sankyo Espha Set to Push Drug Adherence for Cancer AGs, Boost Added Value for Generics

July 9, 2019
BUSINESS Maviret, Lyrica Sell Big; Avastin Presumed No. 1 in FY2018 Drug Ranking: Tally

July 8, 2019
COMMENTARY Drug Pricing Debate for 2020 Reform Going into High Gear; Industry Leery of Post-Election Surprises

July 5, 2019
TRENDS Japan Drug Makers’ Workforce Down 1.3% in FY2018 amid Spate of Voluntary Redundancies

July 4, 2019
TRENDS Drug Makers Now Required to Boost Transparency in Exec Pay; Astellas Ups Bonus, Stock Option Ratio to 70%

July 3, 2019
BUSINESS CheckMate-227 Lung Cancer Data Will Make or Break Opdivo’s Fate: Analyst

July 2, 2019
BUSINESS Takeda’s Medical Unit Revving Up “Patient First Program” as It Looks beyond the Pill

July 1, 2019

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Pharma Renews Call to Scrap “Spillover,” “Huge-Seller” Rules as FY2026 Talks Enter Final Stretch

By Ken Yoshino

Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…